Recurrent Clostridium difficile infections: The importance of the intestinal microbiota

World Journal of Gastroenterology

Volumn 20, Issue 23, 2014, Pages 7416-7423

  Zanella Terrier, Marie Céline ^a   Simonet, Martine Louis ^a   Bichard, Philippe ^a   Frossard, Jean Louis ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Clostridium difficile infection; Clostridium difficile recurrence; Fecal microbiota transplantation; Microbiota; Stool transplantation

Indexed keywords

FIDAXOMICIN; METRONIDAZOLE; PROBIOTIC AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL CRAMP; BACTEROIDES; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG EFFICACY; DYSBIOSIS; ERUCTATION; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HUMAN; INTESTINE FLORA; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NONHUMAN; POLYMERASE CHAIN REACTION; PROTEOBACTERIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT INFECTION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); TRANSPLANTATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; ADVERSE EFFECTS; BIOLOGICAL THERAPY; DRUG EFFECTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; INTESTINE; MICROBIOLOGY; MICROFLORA; PATHOGENICITY; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; RECURRENT DISEASE; TREATMENT OUTCOME; VIRULENCE;

ANTI-BACTERIAL AGENTS; BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; INTESTINES; MICROBIOTA; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; VIRULENCE;

EID: 84902668974     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i23.7416     Document Type: Review

References (44)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, Mc-Donald LC, Pepin J, Wilcox MH. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-455 [PMID: 20307191 DOI: 10.1086/651706]
2. Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J Infect 2013; 66: 115-128 [PMID: 23103666 DOI: 10.1016/j.jinf.2012.10.019]
3. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011; 32: 387-390 [PMID: 21460491 DOI: 10.1086/659156]
4. Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med 2008; 359: 1932-1940 [PMID: 18971494 DOI: 10.1056/NEJMra0707500]
5. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, Kim HP, Dibonaventura MD, Carroll CF, Allen JK, Cook SF, Sandler RS, Kappelman MD, Shaheen NJ. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012; 143: 1179-1187. e1-3 [PMID: 22885331 DOI: 10.1053/j.gastro.2012.08.002]
6. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-2449 [PMID: 16322602]
7. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009; 7: 526-536 [PMID: 19528959 DOI: 10.1038/nrmicro2164]
8. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 2012; 18 Suppl 6: 21-27 [PMID: 23121551 DOI: 10.1111/1469-0691.12046]
9. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007; 45: 1543-1549 [PMID: 18190314 DOI: 10.1086/523582]
10. Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009; 15: 1067-1079 [PMID: 19929973 DOI: 10.1111/j.1469-0691.2009.03099.x]
11. Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014; 20 Suppl 2: 1-26 [PMID: 24118601 DOI: 10.1111/1469-0691.12418]
12. Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, Lee JT. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficileassociated diarrhoea and colitis. Lancet 1983; 2: 1043-1046 [PMID: 6138597]
13. Wenisch C, Parschalk B, Hasenhündl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22: 813-818 [PMID: 8722937]
14. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45: 302-307 [PMID: 17599306]
15. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen K, Borjal D, Elmer GW. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000; 31: 1012-1017 [PMID: 11049785]
16. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002; 97: 1769-1775 [PMID: 12135033]
17. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364: 422-431 [PMID: 21288078 DOI: 10.1056/NEJMoa0910812]
18. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324: 1361 [PMID: 12052801]
19. Pillai A, Nelson R. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev 2008; (1): CD004611 [PMID: 18254055 DOI: 10.1002/14651858.CD004611.pub2]
20. Lynch T, Chong P, Zhang J, Hizon R, Du T, Graham MR, Beniac DR, Booth TF, Kibsey P, Miller M, Gravel D, Mulvey MR. Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate. PLoS One 2013; 8: e53757 [PMID: 23349739 DOI: 10.1371/journal.pone.0053757]
21. Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013; 25: 4-15 [PMID: 23279728 DOI: 10.1111/nmo.12046]
22. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638 [PMID: 15831718]
23. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519 [PMID: 12583961]
24. MacDonald TT, Monteleone I, Fantini MC, Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011; 140: 1768-1775 [PMID: 21530743 DOI: 10.1053/j.gastro.2011.02.047]
25. Neuman MG, Nanau RM. Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res 2012; 160: 29-44 [PMID: 22687961 DOI: 10.1016/j.trsl.2011.09.001]
26. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C. Long-term followup of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 1079-1087 [PMID: 22450732 DOI: 10.1038/ajg.2012.60]
27. Brandt LJ. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol 2013; 108: 177-185 [PMID: 23318479 DOI: 10.1038/ ajg.2012.450]
28. FAO/WHO. Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina, Oct 1-4, 2001. Accessed 2009. Available from: URL: http://www.who.int/foodsafety/publications/ fs_management/en/probiotics.pdf
29. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 2000; 95: S11-S13 [PMID: 10634221]
30. Grehan MJ, Borody TJ, Leis SM, Campbell J, Mitchell H, Wettstein A. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44: 551-561 [PMID: 20716985 DOI: 10.1097/ MCG.0b013e3181e5d06b]
31. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044-1049 [PMID: 21871249 DOI: 10.1016/j.cgh.2011.08.014]
32. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002 [PMID: 22002980 DOI: 10.1093/cid/cir632]
33. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500-508 [PMID: 23511459 DOI: 10.1038/ajg.2013.59]
34. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-859 [PMID: 13592638]
35. Garborg K, Waagsbø B, Stallemo A, Matre J, Sundøy A. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis 2010; 42: 857-861 [PMID: 20662620 DOI: 10.3109/00365548.2010.499541]
36. Burke KE, Lamont JT. Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review. J Am Geriatr Soc 2013; 61: 1394-1398 [PMID: 23869970 DOI: 10.1111/jgs.12378]
37. Russell G, Kaplan J, Ferraro M, Michelow IC. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 2010; 126: e239-e242 [PMID: 20547640 DOI: 10.1542/peds.2009-3363]
38. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415 [PMID: 23323867 DOI: 10.1056/NEJMoa1205037]
39. De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 2013; 11: 1036-1038 [PMID: 23669309 DOI: 10.1016/ j.cgh.2013.04.045]
40. Mole B. FDA gets to grips with faeces. Nature 2013; 498: 147-148 [PMID: 23765468 DOI: 10.1038/498147a]
41. Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis 2012; 55: 1652-1658 [PMID: 22990849 DOI: 10.1093/cid/cis809]
42. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013; 1: 3
43. Hell M, Bernhofer C, Stalzer P, Kern JM, Claassen E. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Benef Microbes 2013; 4: 39-51 [PMID: 23434948 DOI: 10.3920/BM2012.0049]
44. Badger VO, Ledeboer NA, Graham MB, Edmiston CE. Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen. JPEN J Parenter Enteral Nutr 2012; 36: 645-662 [PMID: 22577120 DOI: 10.1177/0148607112446703]